Myeloid cells: unveiling their secrets as biomarkers through next-generation sample preparation

Watch the video or view the poster to learn about: The critical role that myeloid cell biomarkers play in pioneering therapeutic approaches The insights gained from studying myeloid cells in various samples, including whole blood and mouse models Navigating and overcoming technical limitations hindering myeloid cell research, particularly in downstream applications such as immune checkpoint blockade Uncovering the advantages of Curiox Laminar WashTM technology, which offers high-throughput processing, automation, and enhanced data quality with smaller sample volumes

Chyan Ting Ke earned her PhD in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology in Massachusetts. Her doctoral research focused on investigating the modulation of B-cell adaptive immune responses through the nano-scale organization of antigen presentation on biomaterials. Building on her expertise, she extended her research to integrate biocompatible materials in biological applications at the Singapore Immunology Network, A*Star in Singapore.

With a passion for bioengineering immunology and innovation, Ke currently serves as the Director of Bioapplications at Curiox Biosystems. In this role, she leads the development of enabling research and relevant applications using the Curiox Laminar Wash^TM technology.

Please enter your email to access content Read now